BRCA Testing (BRACAnalysis CDx; myChoice CDx) (Myriad)
Customize your policy alerts
Sign up for all Moda Health policy alerts
Know when Moda Health releases new policies or updates existing guidance.
Monitor payer policy activity
Coverage and prior-authorization criteria for Myriad's BRACAnalysis CDx (germline) and myChoice CDx (tumor/somatic) tests for members being considered for specific targeted therapies, including required documentation for prior authorization.
No material clinical or coverage changes in this revision.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.